Suppr超能文献

中国山东省接受抗逆转录病毒治疗的HIV阳性个体中的HIV耐药性

HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.

作者信息

Lin Bin, Sun Xiaoguang, Su Shengli, Lv Cuixia, Zhang Xiaofei, Lin Lin, Wang Rui, Fu Jihua, Kang Dianmin

机构信息

Shandong Center for AIDS Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan, Shandong Province, China.

Qilu Hospital of Shandong University, Jinan, Shandong Province, China.

出版信息

PLoS One. 2017 Jul 27;12(7):e0181997. doi: 10.1371/journal.pone.0181997. eCollection 2017.

Abstract

The efficacy of antiretroviral drugs is limited by the development of drug resistance. Therefore, it is important to examine HIV drug resistance following the nationwide implementation of drug resistance testing in China since 2009. We conducted drug resistance testing in patients who were already on or new to HIV antiretroviral therapy (ART) in Shandong Province, China, from 2011 to 2013, and grouped them based on the presence or absence of drug resistance to determine the effects of age, gender, ethnicity, marital status, educational level, route of transmission and treatment status on drug resistance. We then examined levels of drug resistance the following year. The drug resistance rates of HIV patients on ART in Shandong from 2011 to 2013 were 3.45% (21/608), 3.38% (31/916), and 4.29% (54/1259), per year, respectively. M184V was the most frequently found point mutation, conferring resistance to the nucleoside reverse transcriptase inhibitor, while Y181C, G190A, K103N and V179D/E/F were the most frequent point mutations conferring resistance to the non-nucleoside reverse transcriptase inhibitor. In addition, the protease inhibitor drug resistance mutations I54V and V82A were identified for the first time in Shandong Province. Primary resistance accounts for 20% of the impact factors for drug resistance. Furthermore, it was found that educational level and treatment regimen were high-risk factors for drug resistance in 2011 (P<0.05), while treatment regimen was a high risk factor for drug resistance in 2012 and 2013 (P<0.05). Among the 106 drug-resistant patients, 77 received immediate adjustment of treatment regimen following testing, and 69 (89.6%) showed a reduction in drug resistance the following year. HIV drug resistance has a low prevalence in Shandong Province. However, patients on second line ART regimens and those with low educational level need continuous monitoring. Active drug resistance testing can effectively prevent the development of drug resistance.

摘要

抗逆转录病毒药物的疗效受到耐药性发展的限制。因此,自2009年中国全国范围内开展耐药性检测以来,对HIV耐药情况进行检查很重要。2011年至2013年,我们在中国山东省对已经接受或新开始接受HIV抗逆转录病毒治疗(ART)的患者进行了耐药性检测,并根据是否存在耐药性对他们进行分组,以确定年龄、性别、种族、婚姻状况、教育程度、传播途径和治疗状态对耐药性的影响。然后我们在次年检查了耐药水平。2011年至2013年山东省接受ART治疗的HIV患者的耐药率分别为每年3.45%(21/608)、3.38%(31/916)和4.29%(54/1259)。M184V是最常见的点突变,赋予对核苷类逆转录酶抑制剂的耐药性,而Y181C、G190A、K103N和V179D/E/F是赋予对非核苷类逆转录酶抑制剂耐药性的最常见点突变。此外,蛋白酶抑制剂耐药性突变I54V和V82A在山东省首次被发现。原发耐药占耐药影响因素的20%。此外,发现教育程度和治疗方案在2011年是耐药的高危因素(P<0.05),而治疗方案在2012年和2013年是耐药的高危因素(P<0.05)。在106例耐药患者中,77例在检测后立即接受了治疗方案调整,69例(89.6%)在次年耐药性降低。HIV耐药性在山东省的患病率较低。然而,接受二线ART方案治疗的患者和教育程度低的患者需要持续监测。积极开展耐药性检测可有效预防耐药性的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e229/5531464/3e20f7059e4b/pone.0181997.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验